Sunesis Pharmaceuticals to Host Conference Call on May 7th to Discuss First Quarter 2020 Financial Results and Recent Highlights

On April 30, 2020 Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) reported that it will host a conference call on Thursday, May 7th, 2020 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the first quarter ended March 31, 2020 (Press release, Sunesis, APR 30, 2020, http://ir.sunesis.com/news-releases/news-release-details/sunesis-pharmaceuticals-host-conference-call-may-7th-discuss [SID1234561677]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The call can be accessed by dialing (844) 296-7720 (U.S. and Canada) or (574) 990-1148 (International) and entering passcode 6168259.

To access the live audio webcast, or the subsequent archived recording, visit the "Investors and Media – Calendar of Events" section of the Sunesis website at View Source The webcast will be recorded and available for replay on the company’s website for two weeks.